Image

Quantitative Computed Tomography for Mortality Risk Stratification in ARDS

Quantitative Computed Tomography for Mortality Risk Stratification in ARDS

Recruiting
15 years and older
All
Phase N/A

Powered by AI

Overview

Acute respiratory distress syndrome remains a deadly disease with hospital mortality remaining between 40 to 50%. ARDS mortality risk factors have been identified from patient history, common clinical and biological variables in the lung SAFE study. Part of ARDS mortality is attributable to ventilator-induced lung injury (VILI), in relation with inappropriate settings on the ventilator. Tidal hyperinflation and recruitment/derecruitment during lung inflation are 2 identified mechanisms leading to VILI, that may be identified on computed tomography while poorly identified with variables collected at the bedside.

The aim of this study is to identify whether tidal hyperinflation identified on computed tomography is a risk factor for ARDS mortality, independently from know bio-clinical risk factors.

Eligibility

Inclusion Criteria:

  • Patient aged 15 or older with ARDS according to the Berlin definition
  • invasive mechanical ventilation with PaO2/FiO2 ≤ 300 mm Hg
  • with computed tomography acquired at both end-expiration and end-inspiration, or at both PEEP 5 and 15 cm H2O at end-expiration
  • PEEP setting according to a PEEP/FiO2 table, with secondary adjustment according to hemodynamic tolerance
  • Tidal volume 6 ml/kg of predicted body weight or less

Exclusion Criteria:

  • Use of contrast agent during computed tomography acquisition
  • ARDS criteria onset since more than 72 hours or ECMO onset since more than 72 hours
  • Proven COPD
  • Pneumothorax or bronchopleural fistula
  • Patient with spontaneous breathing preventing realization of end-expiratory and end-inspiratory pauses
  • Previous inclusion in current study
  • Patient under a legal protective measure

Study details
    Acute Respiratory Distress Syndrome

NCT06113276

Hospices Civils de Lyon

15 February 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.